| 注册
首页|期刊导航|中国药理学通报|2013年中国药理学进展研究:国内论文分析

2013年中国药理学进展研究:国内论文分析

穆鑫 赵颖 阿丽塔 李阳 王昕 唐小利 张永祥 杜冠华

中国药理学通报Issue(12):1629-1631,1632,4.
中国药理学通报Issue(12):1629-1631,1632,4.DOI:10.3969/j.issn.1001-1978.2014.12.001

2013年中国药理学进展研究:国内论文分析

2013 report on pharmacology in China:domestic article analysis

穆鑫 1赵颖 2阿丽塔 1李阳 2王昕 3唐小利 3张永祥 4杜冠华5

作者信息

  • 1. 中国医学科学院北京协和医学院药物研究所,北京 100050
  • 2. 中国药理学会,北京 100050
  • 3. 中国医学科学院医学信息研究所,北京 100005
  • 4. 中国药理学会,北京 100050
  • 5. 北京大学医学部,北京 100191
  • 折叠

摘要

Abstract

This article is to investigate the characteristics of pharmacology development in China and to help Chinese scien-tists have a good look at latest progress in this field by analysing the articles published in domestic journals in 201 3.Articles pub-lished in domestic pharmacy related journals originating from the 201 1 edition of A Guide to the Core Journals of China were re-trieved.There were 5450 articles with Chinese authors published in domestic pharmacy related journals in 201 3,including 3842 pharmacology articles.According to the number of articles,the researches mainly concentrate on traditional Chinese medicine and natural products.Universities and colleges were the main organizations in paper publishment in China.The number of ar-ticles from research institutes and hospitals was much lower. Pharmacology in China has achieved considerable progress in 201 3,but challenges still remain.More should be done in disci-pline construction.

关键词

药理学/学科发展/国内论文/研究机构分析/研究领域分析/研究现状

Key words

pharmacology/discipline development/domestic papers/research institution analysis/research area analysis/re-search status

分类

医药卫生

引用本文复制引用

穆鑫,赵颖,阿丽塔,李阳,王昕,唐小利,张永祥,杜冠华..2013年中国药理学进展研究:国内论文分析[J].中国药理学通报,2014,(12):1629-1631,1632,4.

基金项目

中国科学技术协会学会能力提升专项-优秀科技社团奖;国家科技部“重大新药创制”科技重大专项资助项目 ()

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文